| Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors. | |
| | |
MedLine Citation:
|
PMID: 6408124 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Two patients with hemophilia A complicated with high-titer alloantibodies have been treated by repeated infusions of microgram quantities of pure human Factor VIIa. Patient 1 was presented with a gastrocnemius muscle bleeding that involved the knee joint. Upon treatment with Factor VIIa the circumference of the muscle decreased and joint mobility increased substantially. Patient 2 was given Factor VIIa concurrent with tranexamic acid in association with the extraction of two primary molars. No significant gingival bleeding occurred after Factor VIIa and tranexamic acid treatment. Furthermore, no deleterious side effects or increase of the alloantibody level were observed in either patient throughout the Factor VIIa infusion. These results, although limited and preliminary in nature, suggest that trace quantities of Factor VIIa can act as a Factor VIII bypassing activity and restore hemostasis in these patients. |
| | |
Authors:
|
U Hedner; W Kisiel |
Related Documents
:
|
16166584 - Influence of the type of factor viii concentrate on the incidence of factor viii inhibi... 20154074 - The effects of hypoxia on markers of coagulation and systemic inflammation in patients ... 6814244 - An assessment of the fibrinolytic system in hemophilia a. 3085704 - Abnormalities of von willebrand factor in myeloproliferative disease: a relationship wi... 6347754 - Renal prostaglandins and calcium excretion in urolithiasis. 20859894 - Over 10 years with an implantable cardioverter-defibrillator - a long term follow-up of... |
Publication Detail:
|
Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: The Journal of clinical investigation Volume: 71 ISSN: 0021-9738 ISO Abbreviation: J. Clin. Invest. Publication Date: 1983 Jun |
Date Detail:
|
Created Date: 1983-08-11 Completed Date: 1983-08-11 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 7802877 Medline TA: J Clin Invest Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1836-41 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Antigens / immunology* Child Factor VII / therapeutic use* Factor VIII / immunology* Factor VIIa Hemophilia A / drug therapy*, immunology Humans Isoantibodies / analysis* Male Tooth Extraction Tranexamic Acid / therapeutic use |
| Grant Support | |
ID/Acronym/Agency:
|
HL 16919/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Antigens; 0/Isoantibodies; 1197-18-8/Tranexamic Acid; 9001-25-6/Factor VII; 9001-27-8/Factor VIII; EC 3.4.21.21/Factor VIIa |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prostaglandin synthesis by rat glomerular mesangial cells in culture. Effects of angiotensin II and ...
Next Document: Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic...